Tinnitus Patch

Manufacturer
Guangzhou Hongboyuan Trading Co., Ltd. | Henan Jifutang Biotechnology Co., Ltd.
Effective date
2023-10-10
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
full-release
Hydrated at
2026-05-31 23:56:44

Label at a glance#

ProductTinnitus Patch
Active ingredientMENTHOL
Label structure10 sections

Label contents#

Full prescribing information#

OTC - ACTIVE INGREDIENT SECTION

Active ingredient: Menthol 5g/100g

OTC - PURPOSE SECTION

Purpose: Relieve tinnitus

INDICATIONS & USAGE SECTION

Use to: Helps alleviate symptoms of tinnitus

DOSAGE & ADMINISTRATION SECTION

Directions: For external use,remove the antisticking paper,apply the plaster to the Yongquan point on the feet or behind the ears for 8-12 hours each time

WARNINGS SECTION

Precautions

1. This product is an external product,do not take it internally;

2. This product is a disposable external product,not a substitute for drugs or medical equipment;Do not reuse it;

3. Pregnant women,infants,breastfeeding,and those allergic to this product are prohibited;

4. Do not use skin allergies,skin damage,skin diseases and other symptoms;

5. If the skin appears red,itchy and other abnormal conditions during use,please suspend use.

OTC - QUESTIONS SECTION

Questions or comments? +8617846992567

INACTIVE INGREDIENT SECTION

Inactive Ingredients: Frankincense, myrrh

STATEMENT OF IDENTITY SECTION

Other information: Sealed packaging.please keep in a cool and dark place

Produced by:Henan Jifutang Biotechnology Co., Ltd.

No.666,South 600 Miludong,Xiaomaying Village,Pushan Town,Wolong District,Nanyang City

OEM Company: Guangzhou Hongboyuan Trading Co., Ltd.

Made in China

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Same as WARNINGS SECTION

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Tinnitus PatchTinnitus Patchsee label

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
420222menthol 5 % Medicated PatchPSN1
420222menthol 0.05 MG/MG Medicated PatchSCD1
420222menthol 5 % Medicated PatchSY1

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
83713-006-122024-07-30C16284748780-11030e365-701a-111a-e063-dadaa90a10e2Tinnitus Patch 83713-006-12
83713-006-122024-01-30C16284748780-11030e365-701a-111a-e063-dadaa90a10e2Tinnitus Patch 83713-006-12

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
83713-006-11Tinnitus Patch2.1 g in 1 PATCHPATCH2.11
83713-006-12Tinnitus Patch12 in 1 BAGPATCH121

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
83713-006TINNITUS PATCH (MENTHOL) PATCH [GUANGZHOU HONGBOYUAN TRADING CO., LTD.]12 package rows20231014_075a1e20-737c-253d-e063-6294a90a7471.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 4 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
83713-00683713-006-11, 83713-006-12

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 3 matching rows.

Name, UNII, Kind table
NameUNIIKind
MYRRHJC71GJ1F3LIACT
MENTHOLL7T10EIP3AACTIB
FRANKINCENSER9XLF1R1WMIACT

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
075a1e20-737d-253d-e063-6294a90a7471075a1e20-737c-253d-e063-6294a90a74712023-10-10WarningsExact identifier
spl id: 075a1e20-737d-253d-e063-6294a90a7471
spl set id: 075a1e20-737c-253d-e063-6294a90a7471

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.